Vanguard Global Advisers’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
Vanguard Global Advisers's IART Position: Q3 2026 in Review
Vanguard Global Advisers reduced its Integra LifeSciences (IART) stake by 0.95% in Q3 2026, selling an estimated $27.7K and leaving 166,490 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1058.
Vanguard Global Advisers first reported a position in IART in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.02M in Q2 2026. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- Vanguard Global Advisers held 166,490 shares of Integra LifeSciences worth $2.71M as of Q3 2026.
- Vanguard Global Advisers sold 1,604 Integra LifeSciences shares in Q3 2026, an estimated $27.7K.
- Integra LifeSciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1058 holding.
- Vanguard Global Advisers first reported a position in Integra LifeSciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Integra LifeSciences position peaked at $3.02M in Q2 2026.
- 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.